This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Samuel Jockel, Esq., is a senior associate in Alston & Bird’s Litigation & Trial Practice group and a member of the Food, Drug & Device/U.S. Food and Drug Administration team. Sam focuses his practice on regulatory, policy, and litigation matters related to food, beverages, cosmetics, dietary supplements, and drugs. Sam previously served as a trial attorney in USDA’s Office of the General Counsel. He was counsel for the implementation of the National Bioengineered Food Disclosure Standard, playing a key role in providing advice to senior USDA officials, drafting the proposed rulemaking, and defending the USDA in an Administrative Procedure Act challenge.
How are you preparing for January 1, 2022, the mandatory compliance date for the National Bioengineered Food Disclosure Standard? Learn what you should already be doing.
